Change Language

Select Language

Press Release:

Global Natural Killer Cells Therapeutics Market to Reach US$ 5.1 Billion by 2027, Impelled by Growing Prevalence of Chronic Diseases

COVID-19
The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.

Natural Killer Cells Therapeutics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

Market Overview:

The global natural killer cells therapeutics market reached a value of US$ 2.1 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 5.1 Billion by 2027, exhibiting a CAGR of 15.65% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

Natural killer (NK) cells therapeutics target multiple pathogenic antigens with efficient cytotoxicity and reduce the risk of cytokine storms. They can be produced from a variety of sources without relying on patient-specific immune cells. At present, several strategies have been developed, such as ex vivo pre-conditioning with cytokines or small molecular drugs and engineering a chimeric antigen receptor (CAR) NK, which improve the efficacy of NK cells therapeutics. Moreover, researchers are focusing on maximizing the therapeutic effects of allogeneic NK cells through robust expansion, enhanced targeting, and extended persistence of potent immune cells. This can also help unleash a strong and sustained anti-cancer immune-mediated attack.

Natural Killer Cells Therapeutics Market Trends:

A significant rise in the number of individuals with cancer, infectious diseases, and liver disorders represents one of the primary factors fueling the market growth. This can be attributed to unhealthy dietary patterns, lack of physical activities, growing air pollution, and the increasing number of individuals consuming alcohol and tobacco products. Moreover, as the risk of developing cancer rises dramatically with age, the increasing geriatric population across the globe is acting as another growth-inducing factor catalyzing the demand for NK cells therapeutics. Apart from this, as the immune response of cancer patients is not adequate, health companies are developing novel methods and technologies to boost the immune response through allogeneic, off-the-shelf NK cell-based therapies. Furthermore, there is a rise in the number of clinical studies that focus on tumor-targeted antibody strategies to enhance the therapeutic benefit of NK-cell-based therapy while minimizing risks and toxicities. In addition, governing agencies of numerous countries are funding financial schemes for cancer patients, which is creating a favorable outlook for the market.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global natural killer cells therapeutics market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on therapeutics, application and end user.

Breakup by Therapeutics:

  • NK Cell Therapies
  • NK Cell Directed Antibodies
     

Breakup by Application:

  • Cancer 
  • Gastrointestinal Diseases
  • Immunoproliferative Disorders
  • Others
     

Breakup by End User:

  • Hospitals
  • Research Centers and Institutes 
  • Others
     

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa
     

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Affimed GmbH, Bristol-Myers Squibb Company, Fate Therapeutics, Fortress Biotech Inc., Glycostem Therapeutics, Innate Pharma S.A., Kuur Therapeutics Inc. (Athenex Inc.), Nkarta Inc., Takeda Pharmaceutical Company Limited and Ziopharm Oncology Inc.

Report Coverage:

Report Features Details
Base Year of the Analysis 2021
Historical Period 2016-2021
Forecast Period 2022-2027
Units US$ Billion
Segment Coverage Therapeutics, Application, End User, Region
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered Affimed GmbH, Bristol-Myers Squibb Company, Fate Therapeutics, Fortress Biotech Inc., Glycostem Therapeutics, Innate Pharma S.A., Kuur Therapeutics Inc. (Athenex Inc.), Nkarta Inc., Takeda Pharmaceutical Company Limited and Ziopharm Oncology Inc.
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

1   Preface
2   Scope and Methodology
    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3   Executive Summary
4   Introduction
    4.1    Overview
    4.2    Key Industry Trends
5    Global Natural Killer Cells Therapeutics Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6   Market Breakup by Therapeutics
    6.1    NK Cell Therapies
        6.1.1 Market Trends
        6.1.2 Market Forecast
    6.2    NK Cell Directed Antibodies
        6.2.1 Market Trends
        6.2.2 Market Forecast
7   Market Breakup by Application
    7.1    Cancer 
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Gastrointestinal Diseases
        7.2.1 Market Trends
        7.2.2 Market Forecast
    7.3    Immunoproliferative Disorders
        7.3.1 Market Trends
        7.3.2 Market Forecast
    7.4    Others
        7.4.1 Market Trends
        7.4.2 Market Forecast
8   Market Breakup by End User
    8.1    Hospitals
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2    Research Centers and Institutes 
        8.2.1 Market Trends
        8.2.2 Market Forecast
    8.3    Others
        8.3.1 Market Trends
        8.3.2 Market Forecast
9   Market Breakup by Region
    9.1    North America
        9.1.1 United States
           9.1.1.1 Market Trends
           9.1.1.2 Market Forecast
        9.1.2 Canada
           9.1.2.1 Market Trends
           9.1.2.2 Market Forecast
    9.2    Asia-Pacific
        9.2.1 China
           9.2.1.1 Market Trends
           9.2.1.2 Market Forecast
        9.2.2 Japan
           9.2.2.1 Market Trends
           9.2.2.2 Market Forecast
        9.2.3 India
           9.2.3.1 Market Trends
           9.2.3.2 Market Forecast
        9.2.4 South Korea
           9.2.4.1 Market Trends
           9.2.4.2 Market Forecast
        9.2.5 Australia
           9.2.5.1 Market Trends
           9.2.5.2 Market Forecast
        9.2.6 Indonesia
           9.2.6.1 Market Trends
           9.2.6.2 Market Forecast
        9.2.7 Others
           9.2.7.1 Market Trends
           9.2.7.2 Market Forecast
    9.3    Europe
        9.3.1 Germany
           9.3.1.1 Market Trends
           9.3.1.2 Market Forecast
        9.3.2 France
           9.3.2.1 Market Trends
           9.3.2.2 Market Forecast
        9.3.3 United Kingdom
           9.3.3.1 Market Trends
           9.3.3.2 Market Forecast
        9.3.4 Italy
           9.3.4.1 Market Trends
           9.3.4.2 Market Forecast
        9.3.5 Spain
           9.3.5.1 Market Trends
           9.3.5.2 Market Forecast
        9.3.6 Russia
           9.3.6.1 Market Trends
           9.3.6.2 Market Forecast
        9.3.7 Others
           9.3.7.1 Market Trends
           9.3.7.2 Market Forecast
    9.4    Latin America
        9.4.1 Brazil
           9.4.1.1 Market Trends
           9.4.1.2 Market Forecast
        9.4.2 Mexico
           9.4.2.1 Market Trends
           9.4.2.2 Market Forecast
        9.4.3 Others
           9.4.3.1 Market Trends
           9.4.3.2 Market Forecast
    9.5    Middle East and Africa
        9.5.1 Market Trends
        9.5.2 Market Breakup by Country
        9.5.3 Market Forecast
10  SWOT Analysis
    10.1    Overview
    10.2    Strengths
    10.3    Weaknesses
    10.4    Opportunities
    10.5    Threats
11  Value Chain Analysis
12  Porters Five Forces Analysis
    12.1    Overview
    12.2    Bargaining Power of Buyers
    12.3    Bargaining Power of Suppliers
    12.4    Degree of Competition
    12.5    Threat of New Entrants
    12.6    Threat of Substitutes
13  Price Analysis
14  Competitive Landscape
    14.1    Market Structure
    14.2    Key Players
    14.3    Profiles of Key Players
        14.3.1    Affimed GmbH
           14.3.1.1 Company Overview
           14.3.1.2 Product Portfolio
           14.3.1.3 Financials
        14.3.2    Bristol-Myers Squibb Company
           14.3.2.1 Company Overview
           14.3.2.2 Product Portfolio
           14.3.2.3 Financials
           14.3.2.4 SWOT Analysis
        14.3.3    Fate Therapeutics
           14.3.3.1 Company Overview
           14.3.3.2 Product Portfolio
           14.3.3.3 Financials
        14.3.4    Fortress Biotech Inc.
           14.3.4.1 Company Overview
           14.3.4.2 Product Portfolio
           14.3.4.3 Financials
        14.3.5    Glycostem Therapeutics
           14.3.5.1 Company Overview
           14.3.5.2 Product Portfolio
        14.3.6    Innate Pharma S.A.
           14.3.6.1 Company Overview
           14.3.6.2 Product Portfolio
           14.3.6.3 Financials
        14.3.7    Kuur Therapeutics Inc. (Athenex Inc.)
           14.3.7.1 Company Overview
           14.3.7.2 Product Portfolio
        14.3.8    Nkarta Inc.
           14.3.8.1 Company Overview
           14.3.8.2 Product Portfolio
           14.3.8.3 Financials
        14.3.9    Takeda Pharmaceutical Company Limited
           14.3.9.1 Company Overview
           14.3.9.2 Product Portfolio
           14.3.9.3 Financials
           14.3.9.4 SWOT Analysis
        14.3.10    Ziopharm Oncology Inc.
           14.3.10.1 Company Overview
           14.3.10.2 Product Portfolio
           14.3.10.3 Financials

List of Figures

Figure 1: Global: Natural Killer Cells Therapeutics Market: Major Drivers and Challenges
Figure 2: Global: Natural Killer Cells Therapeutics Market: Sales Value (in Billion US$), 2016-2021
Figure 3: Global: Natural Killer Cells Therapeutics Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 4: Global: Natural Killer Cells Therapeutics Market: Breakup by Therapeutics (in %), 2021
Figure 5: Global: Natural Killer Cells Therapeutics Market: Breakup by Application (in %), 2021
Figure 6: Global: Natural Killer Cells Therapeutics Market: Breakup by End User (in %), 2021
Figure 7: Global: Natural Killer Cells Therapeutics Market: Breakup by Region (in %), 2021
Figure 8: Global: Natural Killer Cells Therapeutics (NK Cell Therapies) Market: Sales Value (in Million US$), 2016 & 2021
Figure 9: Global: Natural Killer Cells Therapeutics (NK Cell Therapies) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 10: Global: Natural Killer Cells Therapeutics (NK Cell Directed Antibodies) Market: Sales Value (in Million US$), 2016 & 2021
Figure 11: Global: Natural Killer Cells Therapeutics (NK Cell Directed Antibodies) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 12: Global: Natural Killer Cells Therapeutics (Cancer) Market: Sales Value (in Million US$), 2016 & 2021
Figure 13: Global: Natural Killer Cells Therapeutics (Cancer) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 14: Global: Natural Killer Cells Therapeutics (Gastrointestinal Diseases) Market: Sales Value (in Million US$), 2016 & 2021
Figure 15: Global: Natural Killer Cells Therapeutics (Gastrointestinal Diseases) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 16: Global: Natural Killer Cells Therapeutics (Immunoproliferative Disorders) Market: Sales Value (in Million US$), 2016 & 2021
Figure 17: Global: Natural Killer Cells Therapeutics (Immunoproliferative Disorders) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 18: Global: Natural Killer Cells Therapeutics (Other Applications) Market: Sales Value (in Million US$), 2016 & 2021
Figure 19: Global: Natural Killer Cells Therapeutics (Other Applications) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 20: Global: Natural Killer Cells Therapeutics (Hospitals) Market: Sales Value (in Million US$), 2016 & 2021
Figure 21: Global: Natural Killer Cells Therapeutics (Hospitals) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 22: Global: Natural Killer Cells Therapeutics (Research Centers and Institutes ) Market: Sales Value (in Million US$), 2016 & 2021
Figure 23: Global: Natural Killer Cells Therapeutics (Research Centers and Institutes ) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 24: Global: Natural Killer Cells Therapeutics (Other End Users) Market: Sales Value (in Million US$), 2016 & 2021
Figure 25: Global: Natural Killer Cells Therapeutics (Other End Users) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 26: North America: Natural Killer Cells Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 27: North America: Natural Killer Cells Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 28: United States: Natural Killer Cells Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 29: United States: Natural Killer Cells Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 30: Canada: Natural Killer Cells Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 31: Canada: Natural Killer Cells Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 32: Asia-Pacific: Natural Killer Cells Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 33: Asia-Pacific: Natural Killer Cells Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 34: China: Natural Killer Cells Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 35: China: Natural Killer Cells Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 36: Japan: Natural Killer Cells Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 37: Japan: Natural Killer Cells Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 38: India: Natural Killer Cells Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 39: India: Natural Killer Cells Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 40: South Korea: Natural Killer Cells Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 41: South Korea: Natural Killer Cells Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 42: Australia: Natural Killer Cells Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 43: Australia: Natural Killer Cells Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 44: Indonesia: Natural Killer Cells Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 45: Indonesia: Natural Killer Cells Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 46: Others: Natural Killer Cells Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 47: Others: Natural Killer Cells Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 48: Europe: Natural Killer Cells Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 49: Europe: Natural Killer Cells Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 50: Germany: Natural Killer Cells Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 51: Germany: Natural Killer Cells Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 52: France: Natural Killer Cells Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 53: France: Natural Killer Cells Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 54: United Kingdom: Natural Killer Cells Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 55: United Kingdom: Natural Killer Cells Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 56: Italy: Natural Killer Cells Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 57: Italy: Natural Killer Cells Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 58: Spain: Natural Killer Cells Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 59: Spain: Natural Killer Cells Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 60: Russia: Natural Killer Cells Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 61: Russia: Natural Killer Cells Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 62: Others: Natural Killer Cells Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 63: Others: Natural Killer Cells Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 64: Latin America: Natural Killer Cells Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 65: Latin America: Natural Killer Cells Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 66: Brazil: Natural Killer Cells Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 67: Brazil: Natural Killer Cells Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 68: Mexico: Natural Killer Cells Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 69: Mexico: Natural Killer Cells Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 70: Others: Natural Killer Cells Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 71: Others: Natural Killer Cells Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 72: Middle East and Africa: Natural Killer Cells Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 73: Middle East and Africa: Natural Killer Cells Therapeutics Market: Breakup by Country (in %), 2021
Figure 74: Middle East and Africa: Natural Killer Cells Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 75: Global: Natural Killer Cells Therapeutics Industry: SWOT Analysis
Figure 76: Global: Natural Killer Cells Therapeutics Industry: Value Chain Analysis
Figure 77: Global: Natural Killer Cells Therapeutics Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Natural Killer Cells Therapeutics Market: Key Industry Highlights, 2021 and 2027
Table 2: Global: Natural Killer Cells Therapeutics Market Forecast: Breakup by Therapeutics (in Million US$), 2022-2027
Table 3: Global: Natural Killer Cells Therapeutics Market Forecast: Breakup by Application (in Million US$), 2022-2027
Table 4: Global: Natural Killer Cells Therapeutics Market Forecast: Breakup by End User (in Million US$), 2022-2027
Table 5: Global: Natural Killer Cells Therapeutics Market Forecast: Breakup by Region (in Million US$), 2022-2027
Table 6: Global: Natural Killer Cells Therapeutics Market: Competitive Structure
Table 7: Global: Natural Killer Cells Therapeutics Market: Key Players


Note: We value your privacy and will never rent or sell your email address. Privacy policy

Key Questions Answered in This Report

The global natural killer cells therapeutics market was valued at US$ 2.1 Billion in 2021.

We expect the global natural killer cells therapeutics market to exhibit a CAGR of 15.65% during 2022-
2027.

The continuous development of novel methods and technologies by various healthcare organizations for
boosting the immune response of cancer patients through allogeneic, off-the-shelf NK cell-based
therapies, is primarily driving the global natural killer cells therapeutics market.

The sudden outbreak of the COVID-19 pandemic has led to the rising demand for natural killer cells
therapeutics for emergency treatment of mild-to-moderate coronavirus infection, thereby positively
impacting the global market.

Based on the therapeutics, the global natural killer cells therapeutics market can be segmented into NK
cell therapies and NK cell directed antibodies. Currently, NK cell directed antibodies hold the majority of
the total market share.

Based on the application, the global natural killer cells therapeutics market has been divided into cancer,
gastrointestinal diseases, immunoproliferative disorders, and others. Among these, cancer currently
exhibits a clear dominance in the market.

Based on the end user, the global natural killer cells therapeutics market can be categorized into
hospitals, research centers and institutes, and others. Currently, research centers and institutes account
for the largest market share.

On a regional level, the market has been classified into North America, Asia-Pacific, Europe, Latin
America, and Middle East and Africa, where North America currently dominates the global market.

Some of the major players in the global natural killer cells therapeutics market include Affimed GmbH,
Bristol-Myers Squibb Company, Fate Therapeutics, Fortress Biotech Inc., Glycostem Therapeutics, Innate
Pharma S.A., Kuur Therapeutics Inc. (Athenex Inc.), Nkarta Inc., Takeda Pharmaceutical Company
Limited, and Ziopharm Oncology Inc.

Need more help?

  •   Speak to our experienced analysts for insights on the current market scenarios.
  •   Include additional segments and countries to customize the report as per your requirement.
  •   Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  •   For further assistance, please connect with our analysts.

Related Report

Cell-free Protein Expression Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

Read More

Malaria Vaccine Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2030

Read More

Allergy Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

Read More

Monoclonal Antibodies Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

Read More

Point of Care Molecular Diagnostics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

Read More

Purchase Options




$ 2499

REACH OUT TO US

Call us on

( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )

Drop us an email at

sales@imarcgroup.com

Social Links